Please use this identifier to cite or link to this item:
|Title:||Recurrent inactivating RASA2 mutations in melanoma||Authors:||Qutob, Nouar||Keywords:||Arrhythmia;Cancer genetics;Melanoma - Genetic aspects||Issue Date:||2016||Abstract:||Analysis of 501 melanoma exomes revealed RASA2, encoding a RasGAP, as a tumor-suppressor gene mutated in 5% of melanomas. Recurrent loss-of-function mutations in RASA2 were found to increase RAS activation, melanoma cell growth and migration. RASA2 expression was lost in ≥30% of human melanomas and was associated with reduced patient survival. These findings reveal RASA2 inactivation as a melanoma driver and highlight the importance of Ras GAPs in cancer.||Description:||Authors include:Rand Arafeh, Rafi Emmanuel, Alona Keren-Paz, Jason Madore, Abdel Elkahloun, James S. Wilmott, Jared J. Gartner, Antonella Di Pizio, Sabina Winograd-Katz, Sivasish Sindiri, Ron Rotkopf, Ken Dutton-Regester, Peter Johansson, Antonia Pritchard, Nicola Waddell, Victoria K. Hill, Jimmy C. Lin, Yael Hevroni, Steven A. Rosenberg, Javed Khan, Shifra Ben-Dor, Masha Y. Niv, Igor Ulitsky, Graham J Mann, Richard A. Scolyer, Nicholas K. Hayward, and Yardena Samuels||URI:||http://hdl.handle.net/20.500.11889/4174|
|Appears in Collections:||Fulltext Publications|
Show full item record
checked on Nov 17, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.